Aspira Women’s Health Inc. Long Term Debt

• Aspira Women's Health Inc. showed a decrease of -10.6% in Long Term Debt from 2023 to 2024.
• This data is from Aspira Women's Health Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
• XBRL data for this metric is available from 2010 to 2024 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2016: $1.76 million | Q3 2016: $1.70 million | Q1 2017: $1.59 million | Q2 2017: $1.54 million | Q3 2017: $1.53 million | Q1 2018: $1.43 million | Q2 2018: $1.39 million | Q3 2018: $1.34 million | Q1 2019: $1.24 million | Q2 2019: $1.20 million | Q3 2019: $1.15 million | Q1 2020: $1.05 million | Q2 2020: $1.62 million | Q3 2020: $1.68 million | Q1 2021: $2.72 million | Q2 2021: $2.82 million | Q3 2021: $2.77 million | Q1 2022: $2.65 million | Q2 2022: $2.54 million | Q3 2022: $2.43 million | Q1 2023: $2.20 million | Q2 2023: $1.33 million | Q3 2023: $1.22 million | Q1 2024: $1.35 million | Q2 2024: $1.26 million | Q3 2024: $1.33 million | Q4 2024: $1.28 million | Q1 2025: $1.22 million | Q2 2025: $1.16 million | Q3 2025: $1.10 million.
• Over the full 10 years of available data (2010 to 2024), Aspira Women's Health Inc.'s Long Term Debt has declined by 81.7%.
• Historical annual values: Fiscal year 2024: $1.28 million | Fiscal year 2023: $1.43 million | Fiscal year 2022: $2.32 million | Fiscal year 2021: $2.72 million | Fiscal year 2020: $3.48 million | Fiscal year 2019: $1.10 million | Fiscal year 2018: $1.29 million | Fiscal year 2017: $1.48 million | Fiscal year 2016: $1.67 million | Fiscal year 2010: $7.00 million.
• Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: August 7, 2026